Yuk Lun Cheng
Overview
Explore the profile of Yuk Lun Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu G, Tam C, Lim C, Shi M, Lau E, Ozaki R, et al.
Diabetologia
. 2024 Nov;
68(3):602-614.
PMID: 39531041
Aims/hypothesis: Type 2 diabetes is a complex and heterogeneous disease and the aetiological components underlying the heterogeneity remain unclear in the Chinese and East Asian population. Therefore, we aimed to...
2.
Jin Q, Lau E, Luk A, Tam C, Ozaki R, Lim C, et al.
Diabetologia
. 2024 Feb;
67(5):837-849.
PMID: 38413437
Aims/hypothesis: The aim of this study was to describe the metabolome in diabetic kidney disease (DKD) and its association with incident CVD in type 2 diabetes, and identify prognostic biomarkers....
3.
Tam C, Lim C, Luk A, Shi M, Cheung H, Ng A, et al.
Diabetes Care
. 2023 May;
46(6):1271-1281.
PMID: 37125963
Objective: In this study we aim to unravel genetic determinants of coronary heart disease (CHD) in type 2 diabetes (T2D) and explore their applications. Research Design And Methods: We performed...
4.
Chan H, Ko F, Chan J, Choo K, So L, Lam D, et al.
Int J Chron Obstruct Pulmon Dis
. 2023 Apr;
18:507-519.
PMID: 37056684
Background: Chronic obstructive pulmonary disease (COPD) is a common cause for hospital admission. This study aims to review the hospital burden of COPD in Hong Kong (HK) and the trend...
5.
Jin Q, Lau E, Luk A, Tam C, Ozaki R, Lim C, et al.
Cardiovasc Diabetol
. 2022 Dec;
21(1):293.
PMID: 36587202
Objective: High-density lipoproteins (HDL) comprise particles of different size, density and composition and their vasoprotective functions may differ. Diabetes modifies the composition and function of HDL. We assessed associations of...
6.
Chow K, Ahn C, Dittmer I, Au D, Cheung I, Cheng Y, et al.
Semin Nephrol
. 2022 Dec;
42(4):151268.
PMID: 36577641
Despite the effectiveness of solid organ transplantation, progress to close the gap between donor organs and demand remains slow. An organ shortage increases the waiting time for transplant and involves...
7.
Jiang G, Luk A, Tam C, Ozaki R, Lim C, Chow E, et al.
Diabetes
. 2022 Jan;
71(3):520-529.
PMID: 35043149
We aim to assess the long-term impact of acute kidney injury (AKI) on progression of diabetic kidney disease (DKD) and all-cause mortality and investigate determinants of AKI in Chinese patients...
8.
Jin Q, Luk A, Lau E, Tam C, Ozaki R, Lim C, et al.
Am J Kidney Dis
. 2022 Jan;
80(2):196-206.e1.
PMID: 34999159
Rationale & Objective: Nonalbuminuric diabetic kidney disease (DKD) has become the prevailing DKD phenotype. We compared the risks of adverse outcomes among patients with this phenotype compared with other DKD...
9.
Jiang G, Luk A, Tam C, Lau E, Ozaki R, Chow E, et al.
PLoS Med
. 2020 Jul;
17(7):e1003209.
PMID: 32722720
Background: Type 2 diabetes (T2D) is a progressive disease whereby there is often deterioration in glucose control despite escalation in treatment. There is significant heterogeneity to this progression of glycemia...
10.
Wong C, Chen J, Fung S, Mok M, Cheng Y, Kong I, et al.
BMC Nephrol
. 2020 Feb;
21(1):42.
PMID: 32019528
Background: This study aimed to determine the lifetime cost-effectiveness of first-line dialysis modalities for end-stage renal disease (ESRD) patients under the "Peritoneal Dialysis First" policy. Methods: Lifetime cost-effectiveness analyses from...